It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2017.
2017 | Bangalore, Karnataka, India | ActiveHarwell Lifesciences Private Limited, a active private limited company, was established on 10 March 2017 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74999KA2017PTC101267. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Maliyekal Noor Muhammod Shamsudeen (Director), Nahas Hameed (Director), Urikkunnath Safiya Kunhu (Director). Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at No.22/39, 2Nd Floor, 13Th Cross, 6Th Main, Mahalakshmi Layout, Bangalore, Karnataka, 560086.
U74999KA2017PTC101267
101267
10 March 2017
₹0.50 M
₹0.50 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Harwell Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maliyekal Noor Muhammod Shamsudeen | Director | 10 Mar 2017 | Current |
| Nahas Hameed | Director | 10 Mar 2017 | Current |
| Urikkunnath Safiya Kunhu | Director | 10 Mar 2017 | Current |
| Paul Varghese | Director | 10 Mar 2017 | Current |
| Rahmabeevi | Director | 10 Mar 2017 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Harwell Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 47.21% decrease. The company also saw a substantial fall in profitability, with a 372.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Harwell Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Harwell Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Harwell Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Harwell Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Harwell Lifesciences Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was completed.
Harwell Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Bangalore. was recorded as a recent event.
Progress on Maliyekal Noor Muhammod Shamsudeen was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 9 months . was documented.
Nahas Hameed was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 9 months . was recorded as a recent event.
The activity Urikkunnath Safiya Kunhu was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 9 months . was completed.
The activity Paul Varghese was appointed as a Director was appointed as a Director on 10 Mar 2017 & has been associated with this company since 8 years 9 months . was completed.
The CIN of Harwell Lifesciences Private Limited is U74999KA2017PTC101267.
Harwell Lifesciences Private Limited is headquartered at No.22/39, 2Nd Floor, 13Th Cross, 6Th Main, Mahalakshmi Layout, Bangalore, Karnataka, 560086.
Harwell Lifesciences Private Limited was incorporated on 10 March 2017.
The current directors of Harwell Lifesciences Private Limited are
The primary industry of Harwell Lifesciences Private Limited is Pharma.
Harwell Lifesciences Private Limited is unlisted.
The authorized capital of Harwell Lifesciences Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Harwell Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX